The widespread involvement of GDF15 in diverse cardiovascular and systemic pathophysiological processes, including inflammation, metabolic dysregulation, atherosclerosis, and endothelial dysfunction, likely explains its strong prognostic association with systemic cardiovascular events in patients with PAD, which is consistent with our study findings [47]. Here, GDF15 is linked to atherosclerosis.